TG4010: Clinical Trials

1 trial of TG4010, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow TG4010: new trials by email Literature Review of TG4010 trials Research Report on TG4010

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase IIB/III Of TG4010 Immunotherapy In Patients With Stage IV Non-Small Cell Lung Cancer
TG4010, placebo - Non-Small-Cell Lung Carcinoma
Phase 2 / Phase 3TerminatedTransgene2222012-04-012017-01-05

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)

Sponsors

Transgene (1)

Countries

Belgium (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)

Results publications

PMID 26727163, PMID 28923084